Shortages of interleukin 6 (IL-6) blockers such as tocilizumab are likely as they become the next ‘must-have’ treatment for COVID-19 and Australia must move rapidly to secure supplies, the government has been warned. The Australasian Society of Clinical Immunology and Allergy (ASCIA) has written to Federal minister for health Greg Hunt and the Chief Medical ...
Experts urge government to stockpile IL-6 inhibitors
By Michael Woodhead
19 May 2020